| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 12Cr | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,02400Cr | |
| -1.15% | +2.68% | +54.25% | +71.29% | 66TCr | |
| -1.44% | +0.38% | +20.65% | +75.54% | 45TCr | |
| +0.14% | -0.47% | +30.20% | +40.61% | 35TCr | |
| -1.33% | +4.72% | +24.62% | +47.60% | 30TCr | |
| -1.15% | +0.30% | -0.69% | +11.83% | 25TCr | |
| -1.55% | +1.11% | +54.15% | +72.13% | 24TCr | |
| -0.88% | +1.15% | -14.60% | -54.84% | 21TCr | |
| -0.15% | +3.65% | +31.24% | +100.90% | 19TCr | |
| Average | -0.84% | +1.09% | +28.65% | +52.33% | 40.87TCr | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
Employees
1,178
Sector
Pharmaceuticals
